Preclinical to Clinical Profile of Curcuma longa as Antidiabetic Therapeutics
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Natural product substances have historically served as the most significant source of new leads for pharmaceutical development. Presently, drug discovery and development have adopted rational approaches to explore herbal resources for treating lifestyle-related diseases such as diabetes. For the treatment of diabetes, Curcumin longa has been extensively studied for evaluation of its antidiabetic potential using various in vivo and in vitro models. Literature resources such as PubMed and Google Scholar have been extensively searched to collect documented studies. Various parts of the plant and extracts have proven antidiabetic effects, namely, anti-hyperglycemic, antioxidant, and anti-inflammatory action, through different mechanisms. It is reported that the plant extract or its phytoconstituents regulate glucose and lipid metabolism. The reported study concluded the diversified antidiabetic role of C. longa and its phytoconstituents and, thus, its potential use as an antidiabetic agent.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
Current topics in medicinal chemistry - 23(2023), 24 vom: 27., Seite 2267-2276 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kaushik, Shikha [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Curcuma longa |
|---|
| Anmerkungen: |
Date Revised 24.10.2023 published: Print Citation Status Publisher |
|---|
| doi: |
10.2174/1568026623666230428101440 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356356256 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356356256 | ||
| 003 | DE-627 | ||
| 005 | 20231226070302.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1568026623666230428101440 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1187.xml |
| 035 | |a (DE-627)NLM356356256 | ||
| 035 | |a (NLM)37132313 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kaushik, Shikha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Preclinical to Clinical Profile of Curcuma longa as Antidiabetic Therapeutics |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.10.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a Natural product substances have historically served as the most significant source of new leads for pharmaceutical development. Presently, drug discovery and development have adopted rational approaches to explore herbal resources for treating lifestyle-related diseases such as diabetes. For the treatment of diabetes, Curcumin longa has been extensively studied for evaluation of its antidiabetic potential using various in vivo and in vitro models. Literature resources such as PubMed and Google Scholar have been extensively searched to collect documented studies. Various parts of the plant and extracts have proven antidiabetic effects, namely, anti-hyperglycemic, antioxidant, and anti-inflammatory action, through different mechanisms. It is reported that the plant extract or its phytoconstituents regulate glucose and lipid metabolism. The reported study concluded the diversified antidiabetic role of C. longa and its phytoconstituents and, thus, its potential use as an antidiabetic agent | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a <i>Curcuma longa</i> | |
| 650 | 4 | |a Antidiabetic | |
| 650 | 4 | |a Curcumin | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Hypoglycemic | |
| 650 | 4 | |a Medicinal plants | |
| 700 | 1 | |a Masand, Neeraj |e verfasserin |4 aut | |
| 700 | 1 | |a Iyer, Malliga R |e verfasserin |4 aut | |
| 700 | 1 | |a Patil, Vaishali M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current topics in medicinal chemistry |d 2001 |g 23(2023), 24 vom: 27., Seite 2267-2276 |w (DE-627)NLM117790141 |x 1873-4294 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2023 |g number:24 |g day:27 |g pages:2267-2276 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1568026623666230428101440 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2023 |e 24 |b 27 |h 2267-2276 | ||